In Northampton, authorities have confiscated over 2,000 counterfeit weight-loss injections valued at £250,000 from an illicit facility. The Medicines and Healthcare products Regulatory Agency (MHRA) and Northamptonshire Police conducted the raid, marking it as the largest seizure of weight-loss medication globally.
The confiscated unlicensed pens contained tirzepatide, a key component of Mounjaro and Zepbound, manufactured legally by Eli Lilly in the U.S., along with retratutide, an experimental weight-loss drug still in trial stages and not authorized for use. Eli Lilly cautioned that consumers purchasing these illegal injections would have no knowledge of their actual contents.
Aside from the counterfeit injections, law enforcement also seized raw materials, thousands of empty pens awaiting filling, and £20,000 in cash. MHRA spokesperson noted this as the first discovery of an illegal weight-loss drug production site in the UK, emphasizing the significant risk these products pose to unsuspecting buyers.
Health Secretary Wes Streeting commended the seizure as a victory against criminals jeopardizing public health by selling hazardous weight-loss injections for profit. He urged the public to avoid purchasing weight-loss medications from unregulated sources, advising consultation with healthcare professionals instead.
Andy Morling, head of MHRA’s criminal enforcement unit, highlighted the severity of the situation, emphasizing the dangers of untested and unauthorized products. He warned against purchasing prescription medicines from sources other than registered pharmacies with proper healthcare professional prescriptions.
Despite the operation’s success, no arrests have been reported in connection with the seizure. Legitimate weight-loss injections are exclusively available through the NHS for eligible patients meeting specific criteria.